top of page

BackStop Neural Selected as a Finalist for the AAPM Annual Pain Innovation Challenge

Chief Product Officer Kial Gramley will showcase BackStop Neural's novel advancements.

March 4, 2024 – Backstop Neural, a pioneer in the development of the world’s first thin film-based spinal cord stimulator (SCS) paddle lead, is thrilled to announce that it has been chosen as a finalist to present at the prestigious 3rd Annual Pain Innovation Challenge. Organized by the American Academy of Pain Medicine (AAPM) in collaboration with MIT Hacking Medicine, this event is slated to take place at the AAPM Annual Meeting hosted at the Westin Kierland Resort & Spa in Scottsdale, Arizona on March 9, 2024.

The AAPM-MIT Hacking Medicine Innovation Challenge offers a platform for innovators to showcase their groundbreaking ideas and solutions aimed at addressing challenges in pain management. BackStop Neural is honored to be among the finalists selected to participate in this esteemed event.

During the competition, participants will have the opportunity to pitch their innovations in a dynamic "Shark Tank" style setting, presenting their ideas in front of a distinguished audience comprising patients, healthcare providers, and influential leaders from various institutions and industries, as well as venture capital firms. This presents a valuable chance for finalists like BackStop Neural to gain recognition, secure mentorship, win prizes, and attract potential investors to propel their innovations forward.

"BackStop Neural is dedicated to advancing the field of pain management through innovative neurotechnology solutions," noted CEO Connie Manz. "Being selected as a finalist for the Pain Innovation Challenge underscores our commitment to revolutionizing how pain is understood and treated, ultimately enhancing the quality of life for patients worldwide."

"We are honored and excited to be chosen as a finalist for the 3rd Annual Pain Innovation Challenge," said Chief Product Officer Kial Gramley. "This opportunity not only validates the importance of our work in the field of pain management, but also it provides us with a platform to showcase our innovative solutions to a very knowledgeable audience. We look forward to sharing our vision and collaborating with fellow innovators at this prestigious event."

BackStop Neural extends its gratitude to the organizers of the AAPM-MIT Hacking Medicine Innovation Challenge for this remarkable opportunity and eagerly anticipates the event later this week.

For more information about BackStop Neural and its revolutionary neurotechnology solutions, please visit

About BackStop Neural

BackStop Neural is a pioneering medical device company that specializes in developing advanced spinal cord stimulation solutions for individuals suffering from chronic pain. Through proprietary materials and neurostimulation technology, the company strives to provide patients with a renewed sense of hope and freedom from debilitating conditions. With a team of dedicated experts and a patient-centered approach, BackStop Neural aims to transform the landscape of neurology and elevate the standard of patient care.

For media inquiries, please contact:

Kial Gramley, Chief Product Officer

(956) 219-6752


bottom of page